Inquiry Basket
Catalog | Product Name | CAS Number |
---|---|---|
BADC-01197 | Azido-PEG6-amine | 957486-82-7 |
Azido-PEG6-amine is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. Azido-PEG6-amine is also a non-cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
BADC-01226 | BCN-PEG3-Biotin | 1263166-92-2 |
BCN-PEG3-Biotin combines strain-promoted click chemistry and biotin affinity in a PEGylated ADC linker. Facilitates efficient antibody conjugation and targeted payload delivery in ADC development. | Inquiry | |
BADC-01227 | BCN-PEG3-oxyamine | |
BCN-PEG3-oxyamine is a heterobifunctional ADC linker with bicyclononyne (BCN) for strain-promoted click chemistry and oxyamine for oxime ligation, enabling stable site-specific conjugation. | Inquiry | |
BADC-01229 | BCN-PEG4-OH | |
BCN-PEG4-OH is a hydroxyl-terminated ADC linker featuring BCN for fast, copper-free click chemistry, improving hydrophilicity and stability in antibody-drug conjugate design. | Inquiry | |
BADC-01230 | BCN-PEG4-Ts | |
BCN-PEG4-Ts is a tosylate-activated ADC linker with BCN for strain-promoted cycloaddition and reactive tosyl group for nucleophilic substitution, suitable for site-specific antibody conjugation. | Inquiry | |
BADC-01240 | Cyclooctyne-O-amido-PEG4-PFP ester | |
Cyclooctyne-O-amido-PEG4-PFP ester is a non-cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
BADC-01243 | DBCO-PEG3-oxyamine | 2748394-67-2 |
DBCO-PEG3-oxyamine is a heterobifunctional ADC linker with DBCO for SPAAC and oxyamine for oxime ligation, supporting versatile and stable antibody-payload conjugations in ADC development. | Inquiry | |
BADC-01246 | DBCO-PEG3-TCO | |
DBCO-PEG3-TCO is a dual-functional ADC linker combining DBCO and trans-cyclooctene for SPAAC and IEDDA click chemistry, enabling fast, selective bioconjugation in antibody-drug conjugate synthesis. | Inquiry | |
BADC-01248 | DBCO-PEG4-alkyne | 2741418-16-4 |
DBCO-PEG4-alkyne is a multifunctional ADC linker providing both strain-promoted azide-alkyne cycloaddition (SPAAC) and copper-catalyzed azide-alkyne cycloaddition (CuAAC) functionalities for versatile antibody-payload conjugation. | Inquiry | |
BADC-01294 | Mp-polymer ester | |
Mp-polymer ester is a polymer-based ADC linker intermediate offering flexible conjugation sites and improved solubility, optimizing antibody-drug conjugate synthesis and targeted delivery. | Inquiry | |
BADC-01308 | Propargyl-PEG4-hydrazide | |
Propargyl-PEG4-hydrazide is an alkyne and hydrazide bifunctional ADC linker enabling copper-catalyzed click chemistry and hydrazone bond formation for reversible payload conjugation in targeted therapeutics. | Inquiry | |
BADC-01343 | DOTA-NHS-ester TFA Salt | 2832911-57-4 |
DOTA-NHS-ester TFA Salt is a linker for affibody molecules and is applied in small animals PET, SPECT, and CT. It can be used to label radiotherapeutic agents or imaging probes for the detection of tumors. | Inquiry | |
BADC-01531 | Cyclooctyne-O-amido-PEG4-NHS ester | 2101206-50-0 |
Cyclooctyne-O-amido-PEG4-NHS ester is a key reagent used in the biomedical industry for the efficient conjugation of biological molecules. It enables the site-specific modification of proteins, peptides, and antibodies for various applications such as drug delivery, diagnostics, and targeted therapy. This NHS ester derivative offers high stability and reactivity, making it suitable for the synthesis of bioconjugates used in the treatment of diseases like cancer and autoimmune disorders. | Inquiry | |
BADC-01532 | Cyclooctyne-O-amido-PEG3-NHS ester | 2101206-34-0 |
Cyclooctyne-O-amido-PEG3-NHS ester is a valuable compound used in the biomedical industry for bioconjugation purposes. It acts as a versatile crosslinker for labeling and modification of biomolecules, such as proteins and antibodies. With its NHS ester functionality, it enables efficient and stable conjugation to primary amines. It finds applications in drug delivery systems, diagnostics, and targeted therapeutics, contributing to advancements in treating various diseases. | Inquiry | |
BADC-01533 | Cyclooctyne-O-amido-PEG2-NHS ester | 2101206-22-6 |
Cyclooctyne-O-amido-PEG2-NHS ester is a highly versatile biomedical product extensively employed in the domains of bioconjugation and pharmaceutical transport. It showcases its adeptness as a reactive connector, thus expediting the conjugation of amine-infused entities with biomolecular components. Its cutting-edge composition exhibits remarkable utility in the realm of targeted pharmaceutical transport frameworks, antibody-drug conjugates, as well as bioimaging technologies, thereby augmenting the therapeutic approaches for an array of afflictions encompassing cancer and inflammatory disorders. | Inquiry | |
BADC-01534 | BS3 Crosslinker disodium | 127634-19-9 |
BS3 Crosslinker disodium is a well-known non-cleavable linker in antibody drug development. Furthermore, it acts as an important promoter of protein-protein interactions through complex cross-linking processes. This compound is widely used in research and diagnostics and shows great potential in exploring drug-target interactions and revealing disease mechanisms. | Inquiry | |
BADC-01628 | Azetidin-3-ol hydrochloride | 18621-18-6 |
Azetidin-3-ol hydrochloride is a reactive ADC linker component facilitating site-specific payload attachment, enhancing conjugate stability and efficacy in targeted cancer treatments. | Inquiry | |
BADC-01636 | Glucocorticoid receptor agonist-1 phosphate Gly-Glu-Br | 2344809-82-9 |
Glucocorticoid receptor agonist-1 phosphate Gly-Glu-Br is an ADC linker that can be used to synthesize ABBV-154, ABBV-927, ABBV-368 or their analogs. | Inquiry | |
BADC-01640 | XMT-1519 conjugate-1 | 2720500-19-4 |
XMT-1519 conjugate-1 is a linker for the HER-2 monoclonal antibody XMT-1519. XMT-1519 can be used to synthesize ADC and increase anti-tumor activity. | Inquiry | |
BADC-01645 | 1-Boc-azetidine-3-yl-methanol | 142253-56-3 |
1-Boc-azetidine-3-yl-methanol serves as a cyclic linker intermediate in ADC synthesis, facilitating stable antibody conjugation with enhanced targeting and payload delivery capabilities. | Inquiry |